Search Details

Word: cloninger (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

In the sharpest reaction thus far to the recent decision to put the brakes on the University’s planned expansion into Allston, two professors in the Department of Molecular and Cellular Biology have considered leaving Harvard, fearing that fallout from the slowdown will harm their research.The Universityâ?...

Author: By Esther I. Yi and Peter F. Zhu, CRIMSON STAFF WRITERS | Title: MCB Profs May Leave Harvard | 3/2/2009 | See Source »

Tom Maniatis, an MCB professor renowned for his work in molecular cloning, has made plans to leave Harvard to chair Columbia’s Department of Biochemistry and Molecular Biophysics, according to his lab administrator William C. McCallum.

Author: By Esther I. Yi and Peter F. Zhu, CRIMSON STAFF WRITERS | Title: Profs Weigh Leaving Harvard over Allston Slowdown | 3/1/2009 | See Source »

Though South Korea's labs are the only ones in the world commercially cloning pets today, they may discover their fledgling business is not exactly a growth industry. There are ethical concerns over commercial pet cloning, and at a roughly $150,000 per pooch, the service is currently too expensive...

Author: /time Magazine | Title: South Korea's Pet Clone Wars | 2/10/2009 | See Source »

In the meantime, the small world of canine cloning has become fiercely competitive. Some of the players are duking it out over who owns the patent to commercially clone animals in the first place. Last year, California-based BioArts International, which says it has the sole worldwide license for cloning...

Author: /time Magazine | Title: South Korea's Pet Clone Wars | 2/10/2009 | See Source »

How this battle in Korea' clone wars plays out remains to be seen. But one thing is sure - the SPCAs of the world can rest easy for now. It will be a long time before cloning the family pet is more popular than buying a new one.

Author: /time Magazine | Title: South Korea's Pet Clone Wars | 2/10/2009 | See Source »

Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | Next